Both major political parties have shown interest in remedying high drug prices under Medicare, and drugmakers have bemoaned how rebates to middlemen keep them from reaping every dollar associated with those price tags.
Posted on 13 April 2019.
Both major political parties have shown interest in remedying high drug prices under Medicare, and drugmakers have bemoaned how rebates to middlemen keep them from reaping every dollar associated with those price tags.
Posted in Your MoneyComments (0)
Posted on 05 February 2019.
Few consumers have heard of the secret, business-to-business payments that the Trump administration wants to ban in an attempt to control drug costs.
Posted in Health, Your MoneyComments (0)
Posted on 08 January 2019.
It’s no secret that drug prices are increasing, but to what extent are rising costs explained by the advent of newer, better drugs?
Posted in Health studiesComments (0)
Posted on 06 October 2018.
Drug companies typically have less than 10 years of exclusive rights once a drug hits the marketplace. By Sarah Jane Tribble, Kaiser Health News David Herzberg was alarmed when he heard that Richard Sackler, former chairman of opioid giant Purdue Pharma, was listed as an inventor on a new patent for an opioid addiction treatment. […]
Posted in Health, Your MoneyComments (0)
Posted on 12 August 2018.
Three months after President Donald Trump announced his blueprint to bring down drug prices, administration officials have begun putting some teeth behind the rhetoric.
Posted in Health, Retirement, Your MoneyComments (0)
Posted on 03 August 2018.
An experimental therapy slowed mental decline by 30 percent in patients who got the highest dose in a mid-stage study.
Posted in Health studiesComments (0)